Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice

Zahra Abdossamadi; Negar Seyed; Farnaz Zahedifard; Tahereh Taheri; Yasaman Taslimi; Hossein Montakhab-Yeganeh; Alireza Badirzadeh; Mohammad Vasei; Safoora Gharibzadeh; Sima Rafati

doi:10.1371/journal.pntd.0006123

Loading metrics

Open Access

Peer-reviewed

Research Article

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice

Zahra Abdossamadi,

Roles Investigation, Methodology, Validation, Writing – original draft

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Negar Seyed,

Roles Project administration, Writing – review & editing

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Farnaz Zahedifard,

Roles Investigation, Methodology, Validation

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Tahereh Taheri,

Roles Investigation, Methodology, Software

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Yasaman Taslimi,

Roles Methodology

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Hossein Montakhab-Yeganeh,

Roles Methodology

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Alireza Badirzadeh,

Roles Formal analysis, Methodology

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran
⨯
Mohammad Vasei,

Roles Investigation, Methodology

Affiliation Cell-Based Therapies Research Center, Digestive Disease Research Institute and Department of Pathology, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran
⨯
Safoora Gharibzadeh,

Roles Formal analysis, Validation

Affiliation Department of Epidemiology and Biostatistics, Pasteur Institute of Iran, Tehran, Iran
⨯
Sima Rafati

Roles Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Validation, Writing – review & editing

* E-mail: s_rafati@yahoo.com, sima-rafatisy@pasteur.ac.ir

Affiliation Department of Immunotherapy and Leishmania Vaccine Research, Pasteur institute of Iran, Tehran, Iran

http://orcid.org/0000-0002-7221-1320

⨯

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice

Zahra Abdossamadi,
Negar Seyed,
Farnaz Zahedifard,
Tahereh Taheri,
Yasaman Taslimi,
Hossein Montakhab-Yeganeh,
Alireza Badirzadeh,
Mohammad Vasei,
Safoora Gharibzadeh,
Sima Rafati

Published: December 18, 2017
https://doi.org/10.1371/journal.pntd.0006123

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.
Promastigotes
Is the Subject Area "Promastigotes" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Leishmaniasis
Is the Subject Area "Leishmaniasis" applicable to this article?

Thanks for your feedback.
Cytokine therapy
Is the Subject Area "Cytokine therapy" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.